Angle PLC - Surrey, England-based medical diagnostics company - Raises GBP20.1 million via share placing, marginally above the GBP20.0 million it aimed for.
Places 23.8 million shares equal to 10.7% of existing issued share capital through placing and subscription. Placing price represents a 14% discount to Thursday's closing price.
On Thursday the company said net proceeds will be used to help its commercialisation plans for its Parsortix system. Researchers use Angle's Parsortix system's ability to isolate circulating tumour cells from the blood of prostate cancer patients.
Current stock price: 80.00 pence, down 14% in London on Friday
12-month change: down 32%
By Tom Budszus; tombudszus@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
Angle (AGL)